Passenger lymphocyte syndrome - Epidemiology, pathogenesis, diagnosis, treatment and future directions: A review. [PDF]
Pan Y +6 more
europepmc +1 more source
Evaluation of ABO Blood Groups System with Infection to Hepatitis C Virus: A Tertiary Hospital Study in India [PDF]
Kavi Manasa +4 more
openalex +1 more source
Urinalysis Accuracy for Diagnosis of Bacteremic Urinary Tract Infections in 0–3‐Month‐Old Infants
ABSTRACT Aim To assess urinalysis (UA) accuracy for the diagnosis of bacteremic urinary tract infections (UTI) in young infants. Methods A multi‐center retrospective study collecting 2008–2022 data of infants 0–3‐month‐old with bacteremic UTI (same pathogen in urine and blood).
Hend Heno +11 more
wiley +1 more source
Pure Red Cell Aplasia After ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation Successfully Treated With Daratumumab: Report of Two Cases. [PDF]
Bertone EJ +6 more
europepmc +1 more source
Identification of COVID-19 susceptibility genes by Mendelian randomization. [PDF]
Wang H, Ma K, Wu J, Shan M, Zhang G.
europepmc +1 more source
ABSTRACT Background Allogeneic hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT) have evolved into successful, curative treatments for many severe congenital and acquired diseases. Both use medical products of human origin and should therefore have overarching regulatory frameworks.
Hildegard T. Greinix +14 more
wiley +1 more source
Impact of the ABO and Rh Blood Groups on Malaria Incidence, Recurrence, and Severity Among a Moroccan Military Contingent in the Central African Republic. [PDF]
El Faria W +8 more
europepmc +1 more source
Abstract Aims Obesity is an independent risk factor for chronic kidney disease, and weight loss interventions lead to better kidney outcomes. We aimed to assess whether reducing sedentary behaviour in patients with metabolic syndrome impacts renal glucose uptake rate (GU) during insulin stimulation.
Eleni Rebelos +19 more
wiley +1 more source
Immunocompatibility in transplantation: adapting to a changing therapeutic landscape. [PDF]
Güell-Alonso R +2 more
europepmc +1 more source

